Scott Evans is a senior researcher and faculty member at Harvard University where he teaches “Clinical Trials”. Dr. Evans is a Special Government Employee (SGE) of the FDA, serving on the Advisory Committee for CDRH and as a consultant for CDER. He serves on numerous Data Monitoring Committees (DMCs) including as Chair of the Adolescent Medicine Trials Network (ATN).
Dr. Evans is the Principal Investigator (PI) of the Statistical and Data Management Center of the Neurologic AIDS Research Consortium (NARC, funded by NIH/NINDS) and the Oral HIV/AIDS Research Alliance (OHARA, funded by NIH/NIDCR). Dr. Evans is the Deputy Scientific Director of the Program for Quantitative Sciences in Medicine in the Department of Biostatistics at Harvard University. Dr. Evans was recently awarded the "Robert Zackin Distinguished Collaborative Statistician Award" for significant statistical contributions to HIV research, received a Recognition Award for contributions of statistical expertise from the Harvard School of Public Health, received a Distinguished Service Award from the Council of Chapters of the American Statistical Association, received a Meritorious Outstanding Contributor Award from the Biopharmaceutical Applied Statistics Symposium (BASS), and was inducted as a faculty member into Mu Sigma Rho, the National Honorary Society for Statistics.
Dr. Evans is member of the Human Subjects Committee (Institutional Review Board) of the Harvard School of Public Health and is a member of several Scientific Advisory Boards including "Novel Therapeutics in HIV-Associated Cognitive Disorders" (Johns Hopkins University), the "HIV Neurobehavioral Research Center" (UCSD), and the PML Advisory Board (Genentech). He has served an expert witness for the Commonwealth of Massachusetts and serves on the Editorial Board for several journals. Dr. Evans has taught short courses at the Joint Statistical Meetings (JSM), BASS, the annual meeting of the Society for Clinical Trials (SCT), the FDA-Industry Workshop in Statistics, the Graybill Conference on Biopharmaceutical Statistics, the American Neurological Association, Beth Israel Deaconess Medical Center, and the Pharmaceutical Education Research Institute (PERI).
Dr. Evans is the Past-President of the Boston Chapter of the American Statistical Association (ASA), is the Past-Chair of the Statistics in Sports Section of ASA, is the Chair of the Teaching Statistics in the Health Sciences Section of ASA, is on the Board of Directors for Mu Sigma Rho, was appointed Chair of the Development Committee and the Committee for Statisticians in Defense and National Security of ASA, is Co-Chair of the New England Symposium on Statistics in Sports, will Co-Chair the New England Statistics Symposium (NESS), and served on the Program Committee for the Society for Clinical Trials (SCT), ENAR, the Harvard-Schering-Plough Workshop, and the Graybill Conference on Biopharmaceutical Statistics.